Trial
NCT00366080
Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Narcolepsy
Intervention
GSK189254
Why stopped
Study was terminated based on the interim results of a futility test.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-10